DHG Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DHG?
Owner Type	Number of Shares	Ownership Percentage
Institutions	580,198	0.431%
Individual Insiders	10,697,021	7.95%
Sovereign Wealth Funds	56,626,237	42.1%
Private Companies	66,693,571	49.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 15 shareholders own 102.95% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
51%	Otemon Co., Ltd.	66,693,571	₫7.1t	0%	no data
43.3%	State Capital Investment Corporation	56,626,237	₫6.0t	0%	7.24%
8.18%	Nghia Nguyen	10,689,119	₫1.1t	0%	no data
0.21%	Trade Union Of Dhg Pharma, Endowment Arm	271,167	₫28.7b	0%	no data
0.13%	Sumitomo Mitsui DS Asset Management Company, Limited	165,059	₫17.5b	0%	no data
0.11%	Asset Management One Co., Ltd.	143,460	₫15.2b	0%	no data
0.0026%	Nhung Thi Le	3,426	₫362.8m	0%	no data
0.0024%	Diep Nguyen	3,180	₫336.5m	0%	no data
0.00071%	Huan Ho	929	₫98.3m	0%	no data
0.00038%	Yurieasset Management Co., Ltd.	500	₫52.6m	0%	no data
0.00023%	Lan Thi Vu	300	₫31.8m	0%	no data
0.00005%	Gam Tran	60	₫6.9m	0%	no data
0.00001%	IBK Asset Management Co., Ltd.	7	₫1.4m	0%	no data
0.00001%	Khuong Dinh Doan	7	₫1.4m	0%	no data
0%	Capital Asset Management Co. Ltd.	5	₫0	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 10:22
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

DHG Pharmaceutical Joint Stock Company is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Hang Thi Vu	CGS International
Kien Giang	FPT Securities
Michael Kokalari	Maybank Investment Bank Berhad